Levetiracetam Sun Evropska unija - hrvaščina - EMA (European Medicines Agency)

levetiracetam sun

sun pharmaceutical industries europe b.v. - levetiracetam - epilepsija - drugi antiepileptici sredstva - levetiracetam sun je indiciran kao monoterapija u liječenju parcijalnih napadaja sa ili bez sekundarne generalizacije u bolesnika od 16 godina života s dijagnozom epilepsije. levetiracetam sunce ukazuje i kao pomoćna terapija u liječenju parcijalnih napadaja napad sa ili bez sekundarne generalizacije u odraslih i djece od četiri godine s epilepsijom;u liječenju миоклонические grčevi kod odraslih i adolescenata od 12 godina, s maloljetnika миоклоническая epilepsija;u liječenju primarne генерализованных тонико-клонических grčeva kod odraslih i adolescenata od 12 godina starosti sa idiopatskom epilepsijom postati generalizirani. sunce levetiracetam koncentrat je alternativa za pacijente, kada пероральное primjena privremeno nije moguće.

Temozolomide Sun Evropska unija - hrvaščina - EMA (European Medicines Agency)

temozolomide sun

sun pharmaceutical industries europe b.v. - temozolomida - glioma; glioblastoma - antineoplastična sredstva - Темозоломид sunce je indiciran za liječenje:odrasli pacijenti su prvi put prijavljene мультиформной glioblastoma istovremeno sa terapijom zračenja (lt) i kasnije kao monoterapija liječenje;djeca u dobi od tri godine, tinejdžera i odraslih pacijenata sa malignog глиомой, kao što je mnogolik глиобластома ili анапластическая астроцитома, pokazujući recidiva ili progresije bolesti nakon standardna terapija.

Sitagliptin SUN Evropska unija - hrvaščina - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Ertapenem SUN Evropska unija - hrvaščina - EMA (European Medicines Agency)

ertapenem sun

sun pharmaceutical industries (europe) b.v. - ertapenem natrij - bakterijske infekcije - эртапенем - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 i 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

Sitagliptin / Metformin hydrochloride Sun Evropska unija - hrvaščina - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Cardisure 2,5 mg Hrvaška - hrvaščina - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

cardisure 2,5 mg

eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - pimobendan - aromatizirana tableta - srčani stimulatori, isključujući srčane glikozide, inhibitori fosfodiesteraza - pasa

Forthyron flavoured, 800 mikrograma Hrvaška - hrvaščina - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

forthyron flavoured, 800 mikrograma

eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa

Cardisure 3,5 mg/mL Hrvaška - hrvaščina - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

cardisure 3,5 mg/ml

dechra regulatory b.v., handelsweg 25, 5531 ae bladel, nizozemska - pimobendan - oralna otopina - srčani stimulatori, isključujući srčane glikozide, inhibitori fosfodiesteraza - pasa

Clavudale 40 mg/10 mg Hrvaška - hrvaščina - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

clavudale 40 mg/10 mg

dechra regulatory b.v., handelsweg 25, 5531 ae bladel, nizozemska - amoksicilin (u obliku amoksicilin trihidrata); klavulanska kiselina (u obliku kalijevog klavulanata) - tableta za mačke i pse - mačaka i pasa

Thyroxanil 600 mikrograma Hrvaška - hrvaščina - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

thyroxanil 600 mikrograma

le vet. beheer bv, wilgenweg 7, 3421 tv oudewater, nizozemska - levotiroksinnatrij - tableta za pse i mačke - pasa, mačaka